Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.360
+0.140 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
4.510
+0.150 (3.44%)
After-hours: Mar 9, 2026, 7:35 PM EDT

Cytek Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
90.8598.72167.3296.6364.62
Upgrade
Short-Term Investments
170.68179.1595.1144.55-
Upgrade
Cash & Short-Term Investments
261.53277.86262.41341.15364.62
Upgrade
Cash Growth
-5.88%5.89%-23.08%-6.44%120.67%
Upgrade
Accounts Receivable
62.5160.5955.9348.8629.76
Upgrade
Other Receivables
9.62-0.192.01-0.13
Upgrade
Receivables
72.1360.5956.1250.8829.63
Upgrade
Inventory
48.6644.0161.1748.7832.57
Upgrade
Prepaid Expenses
6.96.583.994.454.21
Upgrade
Restricted Cash
-0.030.332.9-
Upgrade
Other Current Assets
2.797.388.045.880.71
Upgrade
Total Current Assets
392396.45392.06454.02431.73
Upgrade
Property, Plant & Equipment
29.3228.1329.2627.575.85
Upgrade
Long-Term Investments
1.6----
Upgrade
Goodwill
16.716.6616.1810.1410.14
Upgrade
Other Intangible Assets
16.8220.1323.084.334.74
Upgrade
Long-Term Deferred Tax Assets
-33.3730.4920.469.17
Upgrade
Other Long-Term Assets
5.14.763.392.961.67
Upgrade
Total Assets
461.54499.5494.46519.48463.31
Upgrade
Accounts Payable
6.415.533.034.813.03
Upgrade
Accrued Expenses
25.1821.6918.9920.4214.89
Upgrade
Short-Term Debt
0.6----
Upgrade
Current Portion of Long-Term Debt
5.74.660.570.58-
Upgrade
Current Portion of Leases
2.883.762.442.93-
Upgrade
Current Income Taxes Payable
3.071.521.30.252.48
Upgrade
Current Unearned Revenue
29.5726.6124.1314.548.1
Upgrade
Other Current Liabilities
4.43.95.765.524.68
Upgrade
Total Current Liabilities
77.867.6656.2349.0433.18
Upgrade
Long-Term Debt
0.531.051.652.27-
Upgrade
Long-Term Leases
14.047.559.4812.31-
Upgrade
Long-Term Unearned Revenue
18.3416.115.1313.129.79
Upgrade
Other Long-Term Liabilities
9.0911.418.9117.1814.95
Upgrade
Total Liabilities
119.8103.76101.3993.9357.92
Upgrade
Common Stock
0.130.130.130.140.13
Upgrade
Additional Paid-In Capital
441.11430.79423.39442.89423.63
Upgrade
Retained Earnings
-101.74-35.2-29.18-17.03-19.61
Upgrade
Comprehensive Income & Other
2.240.02-1.28-0.70.9
Upgrade
Total Common Equity
341.74395.74393.06425.3405.04
Upgrade
Minority Interest
---0.250.34
Upgrade
Shareholders' Equity
341.74395.74393.06425.55405.39
Upgrade
Total Liabilities & Equity
461.54499.5494.46519.48463.31
Upgrade
Total Debt
23.7417.0214.1418.09-
Upgrade
Net Cash (Debt)
237.79260.85248.27323.06364.62
Upgrade
Net Cash Growth
-8.84%5.06%-23.15%-11.40%124.44%
Upgrade
Net Cash Per Share
1.862.001.842.334.47
Upgrade
Filing Date Shares Outstanding
128.55128.1130.82135.43134.08
Upgrade
Total Common Shares Outstanding
128.55129.21130.71135.37133.75
Upgrade
Working Capital
314.19328.78335.83404.98398.55
Upgrade
Book Value Per Share
2.663.063.013.143.03
Upgrade
Tangible Book Value
308.22358.95353.8410.82390.16
Upgrade
Tangible Book Value Per Share
2.402.782.713.032.92
Upgrade
Buildings
7.927.767.655.55-
Upgrade
Machinery
17.2915.3312.797.634.35
Upgrade
Construction In Progress
1.420.360.260.180.34
Upgrade
Leasehold Improvements
3.523.223.623.483.02
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.